Clinical use of the new biomarker ST2 in patients with chronic heart failure of ischemic genesis: an exercise test
Aim. To study the role of soluble stimulating growth factor expressed by gene 2 (sST2), at rest and after exercise at the end of six-minute walk distance (6MWD) in predicting the development of adverse cardiovascular events (CVA) in patients with coronary artery disease with chronic heart failure (C...
Main Authors: | E. V. Grakova, K. V. Kopieva, А. T. Teplyakov, O. N. Ogurkova, M. V. Soldatenko, A. A. Garganeeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2019-09-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/870 |
Similar Items
-
Prognostic role of ST2 in patients with chronic heart failure of ischemic etiology and carbohydrate metabolism disorders
by: E V Grakova, et al.
Published: (2019-01-01) -
Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocardial revascularization
by: E. V. Grakova, et al.
Published: (2018-10-01) -
Prognosis of cardiovascular events after implantation of a cardioverterdefibrillator in patients with chronic heart failure: the value of increasing concentration of endothelin-1 and soluble forms of ST2 protein in blood plasma
by: A. T. Teplyakov, et al.
Published: (2018-09-01) -
Prognostic value of soluble ST2 and soluble LR11 on mortality and cardiovascular events in peritoneal dialysis patients
by: Yu Bum Choi, et al.
Published: (2020-06-01) -
Using Soluble ST2 to Predict Adverse Postoperative Outcomes in Patients with Impaired Left Ventricular Function Undergoing Coronary Bypass Surgery
by: Ahmet Dolapoglu, et al.
Published: (2019-09-01)